Western blot shows lysates of HepG2 human hepatocellular carcinoma cell line, MDA-MD-231 human breast cancer cell line, NIH-3T3 mouse embryonic fibroblast cell line, and P19 mouse embryonal carcinoma cell line. PVDF ...read more
HMGA2 was detected in immersion fixed IMR‑90 human lung fibroblast cell line using Goat Anti-Human/Mouse HMGA2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3184) at 5 µg/mL for 3 hours at ...read more
Simple Western lane view shows lysates of NIH‑3T3 mouse embryonic fibroblast cell line, loaded at 0.2 mg/mL. A specific band was detected for HMGA2 at approximately 30 kDa (as indicated) using 10 µg/mL of Goat ...read more
Immunocytochemical staining.A: Native CT1258 cells, B: CT1258-EGFP cells, C: CT1258-EGFP-HMGA2 cells. Approximately 50% of the native CT1258 cell line and of CT1258-EGFP cells showed a HMGA2-positive nuclear labelling. ...read more
Nuclear Src activation and association with HMGA2 and SMYD3 gene promoters are observed in patient samples of PDACA Immunohistochemistry of human PDAC tumor samples. Human PDAC slides were immunostained for pY416Src (i) ...read more
Nuclear Src and p300 associate with HMGA2 and SMYD3 gene promoters and regulate their expression in PDAC and MEF cellsA and B. Chromatin-immunoprecipitation (ChIP) and quantitative polymerase-chain reaction (qPCR) ...read more
Immunocytochemical staining.A: Native CT1258 cells, B: CT1258-EGFP cells, C: CT1258-EGFP-HMGA2 cells. Approximately 50% of the native CT1258 cell line and of CT1258-EGFP cells showed a HMGA2-positive nuclear labelling. ...read more
HMGA2 immunohistochemistry in canine OSCC. Immunolabelling of a canine tumour grade II: overview (A), tumour centre (B) and invasive front (C). HMGA2 staining in the tumour centre (B) revealed approx. 25% tumour cells ...read more
HMGA2 immunohistochemistry in human OSCC. Immunolabelling of a human tumour: overview (A), tumour centre (B) and invasive front (C). In the tumour centre (B) lower numbers of tumour cells with nuclear immunolabelling ...read more
HMGA2 immunohistochemistry in canine OSCC. Immunolabelling of a canine tumour grade II: overview (A), tumour centre (B) and invasive front (C). HMGA2 staining in the tumour centre (B) revealed approx. 25% tumour cells ...read more
HMGA2 immunohistochemistry in human OSCC. Immunolabelling of a human tumour: overview (A), tumour centre (B) and invasive front (C). In the tumour centre (B) lower numbers of tumour cells with nuclear immunolabelling ...read more
HMGA2 immunohistochemistry in canine OSCC. Immunolabelling of a canine tumour grade II: overview (A), tumour centre (B) and invasive front (C). HMGA2 staining in the tumour centre (B) revealed approx. 25% tumour cells ...read more
HMGA2 immunohistochemistry in human OSCC. Immunolabelling of a human tumour: overview (A), tumour centre (B) and invasive front (C). In the tumour centre (B) lower numbers of tumour cells with nuclear immunolabelling ...read more
Immunocytochemical staining.A: Native CT1258 cells, B: CT1258-EGFP cells, C: CT1258-EGFP-HMGA2 cells. Approximately 50% of the native CT1258 cell line and of CT1258-EGFP cells showed a HMGA2-positive nuclear labelling. ...read more
E. coli-derived recombinant human HMGA2 Ser2-Asp109 Accession # P52926
Specificity
Detects human and mouse HMGA2 in direct ELISAs and Western blots. In direct ELISAs, approximately 10% cross-reactivity with recombinant human HMGB1 is observed.
Source
N/A
Isotype
IgG
Clonality
Polyclonal
Host
Goat
Gene
HMGA2
Purity Statement
Antigen Affinity-purified
Innovator's Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Buffer
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Preservative
No Preservative
Concentration
LYOPH
Reconstitution Instructions
Reconstitute at 0.2 mg/mL in sterile PBS.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for HMGA2 Antibody [Unconjugated]
BABL
BABLHMGI-C
high mobility group AT-hook 2
High mobility group AT-hook protein 2
high mobility group protein HMGI-C
high-mobility group (nonhistone chromosomal) protein isoform I-C
High-mobility group protein HMGI-C
HMGA2
HMGIC
HMGICSTQTL9
LIPO
Background
HMGA2, previously known as HMGI-C, belongs to the group of high
mobility chromosomal proteins that have the AT-hook DNA-binding motif.
It is highly and ubiquitously expressed during embryogenesis.
Chromosomal rearrangements of the HMGA2 gene and overexpression are
frequently associated with benign and malignant tumors, respectively.
Human and mouse HMGA2 share 95% amino acid sequence identity.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our HMGA2 Antibody [Unconjugated] and receive a gift card or discount.